Multi‐institutional, randomized, double‐blind, placebo‐controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head and neck

In a randomized, double‐blind, placebo‐controlled trial, the mucoadhesive hydrogel MuGard proved to be superior to saline‐bicarbonate rinse in mitigating oral mucositis (OM) symptoms and delaying OM progression. MuGard was safe and well‐tolerated, and favorably affected the rate and incidence of ulc...

Descripción completa

Detalles Bibliográficos
Autores principales: Allison, Ron R., Ambrad, Aaron A., Arshoun, Youssef, Carmel, Richard J., Ciuba, Doug F., Feldman, Elizabeth, Finkelstein, Steven E., Gandhavadi, Ranjini, Heron, Dwight E., Lane, Steven C., Longo, John M., Meakin, Charles, Papadopoulos, Dimitrios, Pruitt, David E., Steinbrenner, Lynn M., Taylor, Michael A., Wisbeck, William M., Yuh, Grace E., Nowotnik, David P., Sonis, Stephen T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164024/
https://www.ncbi.nlm.nih.gov/pubmed/24877167
http://dx.doi.org/10.1002/cncr.28553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164024/
https://www.ncbi.nlm.nih.gov/pubmed/24877167
http://dx.doi.org/10.1002/cncr.28553

Ejemplares similares